dr curigliano on the efficacy of t-dxd in her2-low and her2-ultralow breast cancer
Published 11 days ago • 47 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
6:01
treating low-risk her2-positive breast cancer
-
30:27
advances in her2-positive and her2-low breast cancer
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
0:45
the evolution of her2-low breast cancer from primary to recurrence
-
3:49
her2-targeted therapy for her2 low-expressing breast cancer
-
2:22
can her2 breast cancer be cured? | dr kiley loh
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
54:43
the science of her2-low breast cancer and implications for the pathology team
-
8:12
her2 testing in metastatic breast cancer
-
1:16
her2-low expression in breast cancer
-
31:51
metastatic her2 breast cancer
-
19:47
her2 low breast cancer
-
2:12
dr. curigliano discusses immunotherapy in breast cancer
-
1:51
dr. denduluri on treatment approaches in early-stage hr /her2- breast cancer
-
5:45
her2-positive breast cancer: a paradigm shift in diagnosis and therapy
-
0:59
dr. burstein on the results of the apt trial for her2 breast cancer
-
6:08
first-line treatment of her2-positive metastatic breast cancer
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
35:51
her2 low breast cancer by prof frederique penault liorca
-
1:54
dr. murthy on her2climb trial results in her2 breast cancer
-
3:19
er /her2 metastatic breast cancer